BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18081224)

  • 1. Evaluation of quantitative contrast harmonic imaging to assess malignancy of liver tumors: a prospective controlled two-center study.
    Jung EM; Clevert DA; Schreyer AG; Schmitt S; Rennert J; Kubale R; Feuerbach S; Jung F
    World J Gastroenterol; 2007 Dec; 13(47):6356-64. PubMed ID: 18081224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of malignant liver tumors: biphasic MS-CT versus quantitative contrast harmonic imaging ultrasound.
    Clevert DA; Jung EM; Stock KF; Weckbach S; Feuerbach S; Reiser M; Jung F
    Z Gastroenterol; 2009 Dec; 47(12):1195-202. PubMed ID: 19960397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
    Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
    Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
    Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
    Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative dynamic contrast-enhanced sonography of hepatic tumors.
    Klein D; Jenett M; Gassel HJ; Sandstede J; Hahn D
    Eur Radiol; 2004 Jun; 14(6):1082-91. PubMed ID: 15108017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
    Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
    Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
    von Herbay A; Westendorff J; Gregor M
    J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
    Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
    Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors].
    Jung EM; Clevert DA; Rupp N
    Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of benign hepatic tumors arising in fatty liver with SonoVue and pulse inversion US.
    Bartolotta TV; Midiri M; Galia M; Rollandi GA; Cademartiri F; Lagalla R; Cardinale AE
    Abdom Imaging; 2007; 32(1):84-91. PubMed ID: 16583251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
    von Herbay A; Vogt C; Willers R; Häussinger D
    J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of focal liver lesions in signal-enhanced ultrasound using BR 1, a second-generation ultrasound signal enhancer.
    Peschl R; Werle A; Mathis G
    Dig Dis; 2004; 22(1):73-80. PubMed ID: 15292698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Centrifugal (inside-out) enhancement of liver hemangiomas: a possible atypical appearance on contrast-enhanced US.
    Bartolotta TV; Taibbi A; Galia M; Lo Re G; La Grutta L; Grassi R; Midiri M
    Eur J Radiol; 2007 Dec; 64(3):447-55. PubMed ID: 17433596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results.
    Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C
    Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast enhanced ultrasound for the diagnosis of liver hemangiomas - results of a Romanian multicentre study.
    Sirli R; Sporea I; Săndulescu DL; Popescu A; Dănilă M; Săftoiu A; Spârchez Z; Badea R
    Med Ultrason; 2015 Dec; 17(4):444-50. PubMed ID: 26649337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic accuracy of CEUS in the differential diagnosis of small (≤ 20  mm) and subcentimetric (≤ 10  mm) focal liver lesions in comparison with histology. Results of the DEGUM multicenter trial.
    Strobel D; Bernatik T; Blank W; Schuler A; Greis C; Dietrich CF; Seitz K
    Ultraschall Med; 2011 Dec; 32(6):593-7. PubMed ID: 22161556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
    Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
    Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.